These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8470433)

  • 1. Immunogenicity and pathogenicity of a triple temperature-sensitive modified respiratory syncytial virus in adult volunteers.
    Pringle CR; Filipiuk AH; Robinson BS; Watt PJ; Higgins P; Tyrrell DA
    Vaccine; 1993; 11(4):473-8. PubMed ID: 8470433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines.
    Watt PJ; Robinson BS; Pringle CR; Tyrrell DA
    Vaccine; 1990 Jun; 8(3):231-6. PubMed ID: 2363300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and pathogenicity of temperature-sensitive modified respiratory syncytial virus in adult volunteers.
    McKay E; Higgins P; Tyrrell D; Pringle C
    J Med Virol; 1988 Aug; 25(4):411-21. PubMed ID: 3171557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virus.
    Tolley KP; Marriott AC; Simpson A; Plows DJ; Matthews DA; Longhurst SJ; Evans JE; Johnson JL; Cane PA; Randolph VB; Easton AJ; Pringle CR
    Vaccine; 1996 Dec; 14(17-18):1637-46. PubMed ID: 9032893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.
    Crowe JE; Collins PL; London WT; Chanock RM; Murphy BR
    Vaccine; 1993 Nov; 11(14):1395-404. PubMed ID: 8310760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants.
    Prince GA; Suffin SC; Prevar DA; Camargo E; Sly DL; London WT; Chanock RM
    Infect Immun; 1979 Dec; 26(3):1009-13. PubMed ID: 118925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: II. Genetic analysis of virus recovered during infection.
    Belshe RB; Richardson LS; London WT; Sly DL; Camargo E; Prevar DA; Chanock RM
    J Med Virol; 1978; 3(2):101-10. PubMed ID: 104003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees.
    Crowe JE; Bui PT; Davis AR; Chanock RM; Murphy BR
    Vaccine; 1994 Jul; 12(9):783-90. PubMed ID: 7975856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization.
    Crowe JE; Bui PT; Siber GR; Elkins WR; Chanock RM; Murphy BR
    Vaccine; 1995 Jun; 13(9):847-55. PubMed ID: 7483808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine.
    Herlocher ML; Ewasyshyn M; Sambhara S; Gharaee-Kermani M; Cho D; Lai J; Klein M; Maassab HF
    Vaccine; 1999 Jan; 17(2):172-81. PubMed ID: 9987152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
    Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
    J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses.
    Newman JT; Riggs JM; Surman SR; McAuliffe JM; Mulaikal TA; Collins PL; Murphy BR; Skiadopoulos MH
    J Virol; 2004 Feb; 78(4):2017-28. PubMed ID: 14747566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.
    Karron RA; Wright PF; Crowe JE; Clements-Mann ML; Thompson J; Makhene M; Casey R; Murphy BR
    J Infect Dis; 1997 Dec; 176(6):1428-36. PubMed ID: 9395351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of three vaccines against respiratory syncytial virus in calves.
    Stott EJ; Thomas LH; Taylor G; Collins AP; Jebbett J; Crouch S
    J Hyg (Lond); 1984 Oct; 93(2):251-61. PubMed ID: 6501875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of attenuated respiratory syncytial virus vaccine for infants and children.
    Parrott RH; Kim HW; Brandt CD; Chanock RM
    Dev Biol Stand; 1975; 28():389-99. PubMed ID: 165119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunization of adults against respiratory syncytial virus infection].
    Leshchinskaia NP; Korchanova NL; Pokrovskaia EE; Efremov BV; Padalko IuV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Oct; (10):49-53. PubMed ID: 2609811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and genetic stability of 4 temperature sensitive (ts) mutants of respiratory syncytial (RS) virus in newborn ferrets.
    Belshe RB; Richardson LS; Prevar DA; Camargo E; Chanock RM
    Arch Virol; 1978; 58(4):313-21. PubMed ID: 736795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis.
    Crowe JE; Bui PT; London WT; Davis AR; Hung PP; Chanock RM; Murphy BR
    Vaccine; 1994 Jun; 12(8):691-9. PubMed ID: 8091846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field trials on a live bovine respiratory syncytial virus vaccine in calves.
    Kubota M; Fukuyama S; Takamura K; Izumida A; Kodama K
    J Vet Med Sci; 1992 Oct; 54(5):957-62. PubMed ID: 1420579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of type I IFNs in the in vitro attenuation of live, temperature-sensitive vaccine strains of human respiratory syncytial virus.
    Loveys DA; Kulkarni S; Atreya PL
    Virology; 2000 Jun; 271(2):390-400. PubMed ID: 10860892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.